aluates Reports

$ 0.0

Automative

Global Cancer Biologics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-28M5816

Global Cancer Biologics Market Insights and Forecast to 2028

BUY CHAPTERS

Global Cancer Biologics Market Research Report 2025

Code: QYRE-Auto-28M5816

Report

September 2025

Pages:99

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Novartis

Eli Lilly

Pfizer Inc

Johnson & Johnson

Bristol–Myers Squibb

Merck

Amgen Inc

AbbVie

Gilead Sciences

Astrazeneca plc

Takeda

Merck KGaA

Seagen

Ono Pharmaceutical

GSK

Exelixis Inc

Regeneron

Innovent

Hengrui Medicine

Johnson & Johnson

Cancer Biologics Market Size

The global market for Cancer Biologics was valued at US$ 193350 million in the year 2024 and is projected to reach a revised size of US$ 436080 million by 2031, growing at a CAGR of 12.5% during the forecast period.

Cancer Biologics Market

Cancer Biologic is a medicinal preparation created by a biological process, it is used to treatment and remission cancer symptoms.

North American market for Cancer Biologics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cancer Biologics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Cancer Biologics in Lung Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Cancer Biologics include AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cancer Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biologics.

The Cancer Biologics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Biologics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Biologics Market Report

Report Metric	Details
Report Name	Cancer Biologics Market
Accounted market size in year	US$ 193350 million
Forecasted market size in 2031	US$ 436080 million
CAGR	12.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Monoclonal Antibodies Vaccines Cell and Gene Therapy Others
Segment by Application	Lung Cancer Breast Cancer Prostate Cancer Blood-related Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Biologics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cancer Biologics Market growing?

Ans: The Cancer Biologics Market witnessing a CAGR of 12.5% during the forecast period 2025-2031.

What is the Cancer Biologics Market size in 2031?

Ans: The Cancer Biologics Market size in 2031 will be US$ 436080 million.

Who are the main players in the Cancer Biologics Market report?

Ans: The main players in the Cancer Biologics Market are AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine

What are the Application segmentation covered in the Cancer Biologics Market report?

Ans: The Applications covered in the Cancer Biologics Market report are Lung Cancer, Breast Cancer, Prostate Cancer, Blood-related Cancer, Other

What are the Type segmentation covered in the Cancer Biologics Market report?

Ans: The Types covered in the Cancer Biologics Market report are Monoclonal Antibodies, Vaccines, Cell and Gene Therapy, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Biologics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Monoclonal Antibodies

1.2.3 Vaccines

1.2.4 Cell and Gene Therapy

1.2.5 Others

1.3 Market by Application

1.3.1 Global Cancer Biologics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Lung Cancer

1.3.3 Breast Cancer

1.3.4 Prostate Cancer

1.3.5 Blood-related Cancer

1.3.6 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Biologics Market Perspective (2020-2031)

2.2 Global Cancer Biologics Growth Trends by Region

2.2.1 Global Cancer Biologics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cancer Biologics Historic Market Size by Region (2020-2025)

2.2.3 Cancer Biologics Forecasted Market Size by Region (2026-2031)

2.3 Cancer Biologics Market Dynamics

2.3.1 Cancer Biologics Industry Trends

2.3.2 Cancer Biologics Market Drivers

2.3.3 Cancer Biologics Market Challenges

2.3.4 Cancer Biologics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Biologics Players by Revenue

3.1.1 Global Top Cancer Biologics Players by Revenue (2020-2025)

3.1.2 Global Cancer Biologics Revenue Market Share by Players (2020-2025)

3.2 Global Cancer Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cancer Biologics Revenue

3.4 Global Cancer Biologics Market Concentration Ratio

3.4.1 Global Cancer Biologics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Biologics Revenue in 2024

3.5 Global Key Players of Cancer Biologics Head office and Area Served

3.6 Global Key Players of Cancer Biologics, Product and Application

3.7 Global Key Players of Cancer Biologics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Biologics Breakdown Data by Type

4.1 Global Cancer Biologics Historic Market Size by Type (2020-2025)

4.2 Global Cancer Biologics Forecasted Market Size by Type (2026-2031)

5 Cancer Biologics Breakdown Data by Application

5.1 Global Cancer Biologics Historic Market Size by Application (2020-2025)

5.2 Global Cancer Biologics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cancer Biologics Market Size (2020-2031)

6.2 North America Cancer Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cancer Biologics Market Size by Country (2020-2025)

6.4 North America Cancer Biologics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Biologics Market Size (2020-2031)

7.2 Europe Cancer Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cancer Biologics Market Size by Country (2020-2025)

7.4 Europe Cancer Biologics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cancer Biologics Market Size (2020-2031)

8.2 Asia-Pacific Cancer Biologics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cancer Biologics Market Size by Region (2020-2025)

8.4 Asia-Pacific Cancer Biologics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cancer Biologics Market Size (2020-2031)

9.2 Latin America Cancer Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cancer Biologics Market Size by Country (2020-2025)

9.4 Latin America Cancer Biologics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Biologics Market Size (2020-2031)

10.2 Middle East & Africa Cancer Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cancer Biologics Market Size by Country (2020-2025)

10.4 Middle East & Africa Cancer Biologics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Cancer Biologics Introduction

11.1.4 AbbVie Revenue in Cancer Biologics Business (2020-2025)

11.1.5 AbbVie Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Cancer Biologics Introduction

11.2.4 Johnson & Johnson Revenue in Cancer Biologics Business (2020-2025)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Cancer Biologics Introduction

11.3.4 Novartis Revenue in Cancer Biologics Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Details

11.4.2 Gilead Sciences Business Overview

11.4.3 Gilead Sciences Cancer Biologics Introduction

11.4.4 Gilead Sciences Revenue in Cancer Biologics Business (2020-2025)

11.4.5 Gilead Sciences Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Cancer Biologics Introduction

11.5.4 Roche Revenue in Cancer Biologics Business (2020-2025)

11.5.5 Roche Recent Development

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Details

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Cancer Biologics Introduction

11.6.4 Bristol-Myers Squibb Revenue in Cancer Biologics Business (2020-2025)

11.6.5 Bristol-Myers Squibb Recent Development

11.7 Amgen

11.7.1 Amgen Company Details

11.7.2 Amgen Business Overview

11.7.3 Amgen Cancer Biologics Introduction

11.7.4 Amgen Revenue in Cancer Biologics Business (2020-2025)

11.7.5 Amgen Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Cancer Biologics Introduction

11.8.4 AstraZeneca Revenue in Cancer Biologics Business (2020-2025)

11.8.5 AstraZeneca Recent Development

11.9 Merck & Co

11.9.1 Merck & Co Company Details

11.9.2 Merck & Co Business Overview

11.9.3 Merck & Co Cancer Biologics Introduction

11.9.4 Merck & Co Revenue in Cancer Biologics Business (2020-2025)

11.9.5 Merck & Co Recent Development

11.10 Takeda

11.10.1 Takeda Company Details

11.10.2 Takeda Business Overview

11.10.3 Takeda Cancer Biologics Introduction

11.10.4 Takeda Revenue in Cancer Biologics Business (2020-2025)

11.10.5 Takeda Recent Development

11.11 Merck KGaA

11.11.1 Merck KGaA Company Details

11.11.2 Merck KGaA Business Overview

11.11.3 Merck KGaA Cancer Biologics Introduction

11.11.4 Merck KGaA Revenue in Cancer Biologics Business (2020-2025)

11.11.5 Merck KGaA Recent Development

11.12 Seagen

11.12.1 Seagen Company Details

11.12.2 Seagen Business Overview

11.12.3 Seagen Cancer Biologics Introduction

11.12.4 Seagen Revenue in Cancer Biologics Business (2020-2025)

11.12.5 Seagen Recent Development

11.13 Eli Lilly

11.13.1 Eli Lilly Company Details

11.13.2 Eli Lilly Business Overview

11.13.3 Eli Lilly Cancer Biologics Introduction

11.13.4 Eli Lilly Revenue in Cancer Biologics Business (2020-2025)

11.13.5 Eli Lilly Recent Development

11.14 Ono Pharmaceutical

11.14.1 Ono Pharmaceutical Company Details

11.14.2 Ono Pharmaceutical Business Overview

11.14.3 Ono Pharmaceutical Cancer Biologics Introduction

11.14.4 Ono Pharmaceutical Revenue in Cancer Biologics Business (2020-2025)

11.14.5 Ono Pharmaceutical Recent Development

11.15 Pfizer

11.15.1 Pfizer Company Details

11.15.2 Pfizer Business Overview

11.15.3 Pfizer Cancer Biologics Introduction

11.15.4 Pfizer Revenue in Cancer Biologics Business (2020-2025)

11.15.5 Pfizer Recent Development

11.16 GSK

11.16.1 GSK Company Details

11.16.2 GSK Business Overview

11.16.3 GSK Cancer Biologics Introduction

11.16.4 GSK Revenue in Cancer Biologics Business (2020-2025)

11.16.5 GSK Recent Development

11.17 Exelixis

11.17.1 Exelixis Company Details

11.17.2 Exelixis Business Overview

11.17.3 Exelixis Cancer Biologics Introduction

11.17.4 Exelixis Revenue in Cancer Biologics Business (2020-2025)

11.17.5 Exelixis Recent Development

11.18 Regeneron

11.18.1 Regeneron Company Details

11.18.2 Regeneron Business Overview

11.18.3 Regeneron Cancer Biologics Introduction

11.18.4 Regeneron Revenue in Cancer Biologics Business (2020-2025)

11.18.5 Regeneron Recent Development

11.19 Innovent

11.19.1 Innovent Company Details

11.19.2 Innovent Business Overview

11.19.3 Innovent Cancer Biologics Introduction

11.19.4 Innovent Revenue in Cancer Biologics Business (2020-2025)

11.19.5 Innovent Recent Development

11.20 Hengrui Medicine

11.20.1 Hengrui Medicine Company Details

11.20.2 Hengrui Medicine Business Overview

11.20.3 Hengrui Medicine Cancer Biologics Introduction

11.20.4 Hengrui Medicine Revenue in Cancer Biologics Business (2020-2025)

11.20.5 Hengrui Medicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Novartis

Eli Lilly

Pfizer Inc

Johnson & Johnson

Bristol–Myers Squibb

Merck

Amgen Inc

AbbVie

Gilead Sciences

Astrazeneca plc

Takeda

Merck KGaA

Seagen

Ono Pharmaceutical

GSK

Exelixis Inc

Regeneron

Innovent

Hengrui Medicine

Johnson & Johnson

List of Tables

Table 1. Global Cancer Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Vaccines

Table 4. Key Players of Cell and Gene Therapy

Table 5. Key Players of Others

Table 6. Global Cancer Biologics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Cancer Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Cancer Biologics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Cancer Biologics Market Share by Region (2020-2025)

Table 10. Global Cancer Biologics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Cancer Biologics Market Share by Region (2026-2031)

Table 12. Cancer Biologics Market Trends

Table 13. Cancer Biologics Market Drivers

Table 14. Cancer Biologics Market Challenges

Table 15. Cancer Biologics Market Restraints

Table 16. Global Cancer Biologics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Cancer Biologics Market Share by Players (2020-2025)

Table 18. Global Top Cancer Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biologics as of 2024)

Table 19. Ranking of Global Top Cancer Biologics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Cancer Biologics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Cancer Biologics, Headquarters and Area Served

Table 22. Global Key Players of Cancer Biologics, Product and Application

Table 23. Global Key Players of Cancer Biologics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Cancer Biologics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Cancer Biologics Revenue Market Share by Type (2020-2025)

Table 27. Global Cancer Biologics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Cancer Biologics Revenue Market Share by Type (2026-2031)

Table 29. Global Cancer Biologics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Cancer Biologics Revenue Market Share by Application (2020-2025)

Table 31. Global Cancer Biologics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Cancer Biologics Revenue Market Share by Application (2026-2031)

Table 33. North America Cancer Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Cancer Biologics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Cancer Biologics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Cancer Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Cancer Biologics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Cancer Biologics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Cancer Biologics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Cancer Biologics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Cancer Biologics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Cancer Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Cancer Biologics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Cancer Biologics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Cancer Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Cancer Biologics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Cancer Biologics Market Size by Country (2026-2031) & (US$ Million)

Table 48. AbbVie Company Details

Table 49. AbbVie Business Overview

Table 50. AbbVie Cancer Biologics Product

Table 51. AbbVie Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 52. AbbVie Recent Development

Table 53. Johnson & Johnson Company Details

Table 54. Johnson & Johnson Business Overview

Table 55. Johnson & Johnson Cancer Biologics Product

Table 56. Johnson & Johnson Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 57. Johnson & Johnson Recent Development

Table 58. Novartis Company Details

Table 59. Novartis Business Overview

Table 60. Novartis Cancer Biologics Product

Table 61. Novartis Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 62. Novartis Recent Development

Table 63. Gilead Sciences Company Details

Table 64. Gilead Sciences Business Overview

Table 65. Gilead Sciences Cancer Biologics Product

Table 66. Gilead Sciences Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 67. Gilead Sciences Recent Development

Table 68. Roche Company Details

Table 69. Roche Business Overview

Table 70. Roche Cancer Biologics Product

Table 71. Roche Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 72. Roche Recent Development

Table 73. Bristol-Myers Squibb Company Details

Table 74. Bristol-Myers Squibb Business Overview

Table 75. Bristol-Myers Squibb Cancer Biologics Product

Table 76. Bristol-Myers Squibb Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 77. Bristol-Myers Squibb Recent Development

Table 78. Amgen Company Details

Table 79. Amgen Business Overview

Table 80. Amgen Cancer Biologics Product

Table 81. Amgen Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 82. Amgen Recent Development

Table 83. AstraZeneca Company Details

Table 84. AstraZeneca Business Overview

Table 85. AstraZeneca Cancer Biologics Product

Table 86. AstraZeneca Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 87. AstraZeneca Recent Development

Table 88. Merck & Co Company Details

Table 89. Merck & Co Business Overview

Table 90. Merck & Co Cancer Biologics Product

Table 91. Merck & Co Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 92. Merck & Co Recent Development

Table 93. Takeda Company Details

Table 94. Takeda Business Overview

Table 95. Takeda Cancer Biologics Product

Table 96. Takeda Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 97. Takeda Recent Development

Table 98. Merck KGaA Company Details

Table 99. Merck KGaA Business Overview

Table 100. Merck KGaA Cancer Biologics Product

Table 101. Merck KGaA Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 102. Merck KGaA Recent Development

Table 103. Seagen Company Details

Table 104. Seagen Business Overview

Table 105. Seagen Cancer Biologics Product

Table 106. Seagen Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 107. Seagen Recent Development

Table 108. Eli Lilly Company Details

Table 109. Eli Lilly Business Overview

Table 110. Eli Lilly Cancer Biologics Product

Table 111. Eli Lilly Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 112. Eli Lilly Recent Development

Table 113. Ono Pharmaceutical Company Details

Table 114. Ono Pharmaceutical Business Overview

Table 115. Ono Pharmaceutical Cancer Biologics Product

Table 116. Ono Pharmaceutical Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 117. Ono Pharmaceutical Recent Development

Table 118. Pfizer Company Details

Table 119. Pfizer Business Overview

Table 120. Pfizer Cancer Biologics Product

Table 121. Pfizer Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 122. Pfizer Recent Development

Table 123. GSK Company Details

Table 124. GSK Business Overview

Table 125. GSK Cancer Biologics Product

Table 126. GSK Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 127. GSK Recent Development

Table 128. Exelixis Company Details

Table 129. Exelixis Business Overview

Table 130. Exelixis Cancer Biologics Product

Table 131. Exelixis Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 132. Exelixis Recent Development

Table 133. Regeneron Company Details

Table 134. Regeneron Business Overview

Table 135. Regeneron Cancer Biologics Product

Table 136. Regeneron Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 137. Regeneron Recent Development

Table 138. Innovent Company Details

Table 139. Innovent Business Overview

Table 140. Innovent Cancer Biologics Product

Table 141. Innovent Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 142. Innovent Recent Development

Table 143. Hengrui Medicine Company Details

Table 144. Hengrui Medicine Business Overview

Table 145. Hengrui Medicine Cancer Biologics Product

Table 146. Hengrui Medicine Revenue in Cancer Biologics Business (2020-2025) & (US$ Million)

Table 147. Hengrui Medicine Recent Development

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Cancer Biologics Picture

Figure 2. Global Cancer Biologics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cancer Biologics Market Share by Type: 2024 VS 2031

Figure 4. Monoclonal Antibodies Features

Figure 5. Vaccines Features

Figure 6. Cell and Gene Therapy Features

Figure 7. Others Features

Figure 8. Global Cancer Biologics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Cancer Biologics Market Share by Application: 2024 VS 2031

Figure 10. Lung Cancer Case Studies

Figure 11. Breast Cancer Case Studies

Figure 12. Prostate Cancer Case Studies

Figure 13. Blood-related Cancer Case Studies

Figure 14. Other Case Studies

Figure 15. Cancer Biologics Report Years Considered

Figure 16. Global Cancer Biologics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Cancer Biologics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Cancer Biologics Market Share by Region: 2024 VS 2031

Figure 19. Global Cancer Biologics Market Share by Players in 2024

Figure 20. Global Top Cancer Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biologics as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Cancer Biologics Revenue in 2024

Figure 22. North America Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Cancer Biologics Market Share by Country (2020-2031)

Figure 24. United States Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Cancer Biologics Market Share by Country (2020-2031)

Figure 28. Germany Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Cancer Biologics Market Share by Region (2020-2031)

Figure 36. China Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Cancer Biologics Market Share by Country (2020-2031)

Figure 44. Mexico Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Cancer Biologics Market Share by Country (2020-2031)

Figure 48. Turkey Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Cancer Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. AbbVie Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 52. Johnson & Johnson Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 54. Gilead Sciences Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 55. Roche Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 57. Amgen Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 58. AstraZeneca Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 59. Merck & Co Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 60. Takeda Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 61. Merck KGaA Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 62. Seagen Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 63. Eli Lilly Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 64. Ono Pharmaceutical Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 65. Pfizer Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 66. GSK Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 67. Exelixis Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 68. Regeneron Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 69. Innovent Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 70. Hengrui Medicine Revenue Growth Rate in Cancer Biologics Business (2020-2025)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cancer Immunotherapies Market Insights Forecast to 2030

Global Cancer Biopharmaceuticals Market Insights Forecast to 2030

Global Cancer Biotherapy Market Insights Forecast to 2030

Global Innovations in Biologics and Biosimilars Market Research Report 2024

Global Biologics and Biosimilars Market Research Report 2025

Global Biologics Drug Development Market Research Report 2024

Global Biologic Medical Product Market Research Report 2025

Global Biologics Drug Discovery Market Research Report 2024

Global Subcutaneous Biologics Market Research Report 2024

Innovative Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biologics Drug Discovery and Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Based Cancer Therapeutics Market Research Report 2024

Biotech Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biologic Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bladder Cancer Biologics Market Research Report 2024

Innovative Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biologics Analytical Services Market Research Report 2024

Global Non oncology Biopharmaceuticals Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions